Related references
Note: Only part of the references are listed.Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination
Dongngan T. Truong et al.
CIRCULATION (2022)
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
Matthew E. Oster et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Myocardial Injury Pattern at MRI in COVID-19 Vaccine-associated Myocarditis
Matteo Fronza et al.
RADIOLOGY (2022)
CMR Imaging 6 Months After Myocarditis Associated with the BNT162b2 mRNA COVID-19 Vaccine
Gabriel Amir et al.
PEDIATRIC CARDIOLOGY (2022)
Comparison of Multisystem Inflammatory Syndrome in Children-Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine-Related Myocarditis in Children
Trisha Patel et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022
Jason P. Block et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
Kristin Goddard et al.
VACCINE (2022)
Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents
Suchitra Rao et al.
JAMA PEDIATRICS (2022)
Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis
Stephanie M. Hadley et al.
EUROPEAN JOURNAL OF PEDIATRICS (2022)
US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples
Ruixuan Jiang et al.
QUALITY OF LIFE RESEARCH (2021)
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
Guy Witberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L
Joel W. Hay et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
Mortality and ventricular arrhythmia after acute myocarditis: a nationwide registry-based follow-up study
Kristian Hay Kragholm et al.
OPEN HEART (2021)
Diagnosis and Management of Myocarditis in Children A Scientific Statement From the American Heart Association
Yuk M. Law et al.
CIRCULATION (2021)
COVID-19 Vaccination-Associated Myocarditis in Adolescents
Supriya S. Jain et al.
PEDIATRICS (2021)
Prognostic Significance of Nonischemic Myocardial Fibrosis in Patients With Normal LV Volumes and Ejection-Fraction
Amrit S. Lota et al.
JACC-CARDIOVASCULAR IMAGING (2021)
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
Julia W. Gargano et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Persistence of Late Gadolinium Enhancement on Follow-Up CMR Imaging in Children with Acute Myocarditis
Siddharth Dubey et al.
PEDIATRIC CARDIOLOGY (2020)
United States Valuation of EQ-5D-5L Health States Using an International Protocol
A. Simon Pickard et al.
VALUE IN HEALTH (2019)
Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry
Enrico Ammirati et al.
CIRCULATION (2018)
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation Expert Recommendations
Vanessa M. Ferreira et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis
Christoph Grani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function ITAMY Study
Giovanni Donato Aquaro et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
EQ-5D and the EuroQol Group: Past, Present and Future
Nancy J. Devlin et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2017)
Myocarditis in Clinical Practice
Gianfranco Sinagra et al.
MAYO CLINIC PROCEEDINGS (2016)
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease A Scientific Statement From the American Heart Association and American College of Cardiology
Robert O. Bonow et al.
CIRCULATION (2015)
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis A Scientific Statement From the American Heart Association and American College of Cardiology
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Tom T. Shimabukuro et al.
VACCINE (2015)
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study
M. F. Janssen et al.
QUALITY OF LIFE RESEARCH (2013)
Demographics, Trends, and Outcomes in Pediatric Acute Myocarditis in the United States, 2006 to 2011
Sunil J. Ghelani et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Long-Term Follow-Up of Biopsy-Proven Viral Myocarditis Predictors of Mortality and Incomplete Recovery
Stefan Gruen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
M. Herdman et al.
QUALITY OF LIFE RESEARCH (2011)
Medical Progress: Myocarditis.
Leslie T. Cooper
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Anxiety and depressive symptoms and anxiety sensitivity in youngsters with noncardiac chest pain and benign heart murmurs
JD Lipsitz et al.
JOURNAL OF PEDIATRIC PSYCHOLOGY (2004)